A Randomized, Open- Label, Parallel Controlled Study to Compare the Pharmacokinetics of JS005 With a Pre-filled Syringe and a Pre-filled Automatic Syringe Subcutaneously Injected in Healthy Volunteers
Latest Information Update: 18 Dec 2024
Price :
$35 *
At a glance
- Drugs JS 005 (Primary)
- Indications Ankylosing spondylitis; Axial spondyloarthritis; Plaque psoriasis; Psoriatic arthritis
- Focus Pharmacokinetics
- Sponsors Shanghai Junshi Biosciences
- 18 Dec 2024 New trial record